Related Experiment Videos
Prognostic factors in lymph node-positive prostate cancer.
Matthias D Hofer1, Rainer Kuefer, Wei Huang
1Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Urology
|May 16, 2006
Summary
Lymph node metastasis in prostate cancer (PCa) is heterogeneous. Lymphovascular invasion and primary tumor nuclear grade independently predict PSA recurrence in men with lymph node-positive PCa.
Area of Science:
- Urology
- Oncology
- Pathology
Background:
- Prostate cancer (PCa) with lymph node metastasis presents varying incidence globally.
- Understanding these metastases is crucial for predicting patient outcomes.
Purpose of the Study:
- To characterize lymph node metastases in prostate cancer.
- To identify parameters predicting patient outcomes, specifically prostate-specific antigen (PSA) recurrence.
Main Methods:
- Analysis of 1148 patients undergoing radical prostatectomy, with a focus on 201 patients (18%) diagnosed with lymph node-positive PCa.
- Evaluation of lymph node metastasis characteristics including Gleason pattern, extranodal extension, and lymphovascular invasion (LVI).
Main Results:
- Lymph node metastases exhibited growth patterns similar to primary PCa.
- Gleason pattern 4/5, extranodal extension, and LVI were observed in a significant proportion of patients.
- Increased risk of PSA recurrence was associated with Gleason pattern 4/5, lymph node LVI, and primary tumor nuclear grade.
Conclusions:
- Lymph node metastases in PCa are heterogeneous and correlate with the primary tumor.
- Lymphovascular invasion in lymph nodes and primary tumor nuclear grade are independent predictors of PSA recurrence.
- These factors can aid in predicting recurrence and guiding follow-up for patients with lymph node-positive PCa.